HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PPARgamma influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis.

Abstract
Peroxisome proliferator-activated receptor gamma (PPARgamma), a member of the nuclear receptor superfamily, plays a role in adipocyte differentiation, type II diabetes, macrophage response to inflammation and is suggested to influence carcinogen-induced colon cancer. Studies done in vitro and in vivo also revealed that PPARgamma ligands might promote differentiation and/or regression of mammary tumors. To directly evaluate the role of PPARgamma in mammary carcinogenesis, PPARgamma wild-type (+/+) or heterozygous (+/-) mice were administered 1 mg 7,12-dimethylbenz[a]anthracene (DMBA) by gavage once a week for 6 weeks and followed for a total of 25 weeks. Compared with congenic PPARgamma(+/+) littermate controls, PPARgamma(+/-) mice had early evidence for increased susceptibility to DMBA-mediated carcinogenesis based on a 1.6-fold increase in the percentage of mice with skin papillomas, as well as a 1.7-fold increase in the numbers of skin papillomas per mouse (P < 0.05). Similarly, PPARgamma(+/-) mice also had a 1.5-fold decreased survival rate (P = 0.059), and a 1.7-fold increased incidence of total tumors per mouse (P < 0.01). Moreover, PPARgamma(+/-) mice had an almost 3-fold increase in mammary adenocarcinomas (P < 0.05), an over 3-fold increase in ovarian granulosa cell carcinomas (P < 0.05), an over 3-fold increase in malignant tumors (P < 0.02) and a 4.6-fold increase in metastatic incidence. These results are the first to demonstrate an increased susceptibility in vivo of PPARgamma haploinsufficiency to DMBA-mediated carcinogenesis and suggest that PPARgamma may act as a tumor modifier of skin, ovarian and breast cancers. The data also support evidence suggesting a beneficial role for PPARgamma-specific ligands in the chemoprevention of mammary, ovarian and skin carcinogenesis.
AuthorsChristopher J Nicol, Michung Yoon, Jerrold M Ward, Masamichi Yamashita, Katsumi Fukamachi, Jeffrey M Peters, Frank J Gonzalez
JournalCarcinogenesis (Carcinogenesis) Vol. 25 Issue 9 Pg. 1747-55 (Sep 2004) ISSN: 0143-3334 [Print] England
PMID15073042 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • DNA Primers
  • RNA, Messenger
  • Receptors, Cytoplasmic and Nuclear
  • Transcription Factors
  • 9,10-Dimethyl-1,2-benzanthracene
Topics
  • 9,10-Dimethyl-1,2-benzanthracene (toxicity)
  • Animals
  • DNA Primers (chemistry)
  • Disease Susceptibility
  • Female
  • Heterozygote
  • Humans
  • Mammary Neoplasms, Experimental (chemically induced, pathology)
  • Mice
  • Ovarian Neoplasms (chemically induced, pathology)
  • RNA, Messenger (genetics, metabolism)
  • Receptors, Cytoplasmic and Nuclear (genetics, physiology)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Skin Neoplasms (chemically induced, pathology)
  • Survival Rate
  • Transcription Factors (genetics, physiology)
  • Zinc Fingers

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: